Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
24 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Aloxi Capsules Articles
Vifor gets certain rights to Helsinn's netupitant-palonosetron
16 May 2013
Helsinn out-licenses netupitant-palonosetron fixed dose combo in South Korea
25 September 2012
Eisai/Helsinn's Aloxi capsules approved in USA
1 September 2008
Showing 1-3 of 3 articles
1
Hot Topics
Most Read
US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
Boehringer Ingelheim gets FDA warning letter on cGMP failures
Italy's pharma market slump set to continue, warns GlobalData
US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
Boehringer Ingelheim gets FDA warning letter on cGMP failures
Italy's pharma market slump set to continue, warns GlobalData